2007 | Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells. | Jiang, MC; Luo, SF; Li, LT; Lin, CC; Du, SY; Lin, CY; Hsu, YW; Liao, CF | Journal of experimental & clinical cancer research : CR 26(1), 91-99 | | | |
2015 | Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study | Ko, TM ; Tsai, CY; Chen, SY; Chen, KS; Yu, KH; Chu, CS; Huang, CM; Wang, CR; Weng, CT; Yu, CL; Hsieh, SC; Tsai, JC; Lai, WT; Tsai, WC; Yin, GD; Ou, TT; Cheng, KH; Yen, JH; Liou, TL; Lin, TH; Chen, DY; Hsiao, PJ; Weng, MY; Chen, YM; Chen, CH; Liu, MF; Yen, HW; Lee, JJ; Kuo, MC; Wu, CC; Hung, SY; Luo, SF; Yang, YH; Chuang, HP; Chou, YC; Liao, HT; Wang, CW; Huang, CL; Chang, CS; Lee, MT ; Chen, P; Wong, CS; Chen, CH ; Wu, JY ; Chen, YT ; Shen, CY ; Taiwan Allopurinol-SCAR Consortium | BMJ-British Medical Journal 351, h4848 | | | |